← Back to Clinical Trials
Recruiting NCT07710352

NCT07710352 Low Gas Pressure vs Standard Gas Pressure in Robotic Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07710352
Status Recruiting
Phase
Sponsor Weill Medical College of Cornell University
Condition Robotic Surgery
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-07-30
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
AirSeal Robotic SolutionStandard-pressure pneumoperitoneum (15 mmHg)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2026-07-30 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

During surgery that is done using a robot, the surgeon needs to put carbon dioxide gas into the belly to lift the belly wall. This is done so the surgeon can adequately see all the body organs and operate safely. Many surgeons currently use a standard pressure of 15 mmHg (a unit to measure pressure). However, many patients find the use of this pressure to be painful after surgery. New research has shown that using a lower pressure with a device called "AirSeal" can safely reduce pain and lead to faster recovery after surgery. The goal of this clinical trial is to learn if using a lower gas pressure with the AirSeal device during robotic surgery, compared to standard gas pressure with conventional devices, helps adults feel less pain and recover faster. The study includes adults aged 18 or older having robotic at New York-Presbyterian Hospital/Weill Cornell Medical Center. The main questions this clinical trial aims to answer are: 1. Does using lower gas pressure shorten the time people spend in the recovery room after surgery? 2. Does using lower gas pressure lead to less pain and reduce the need for pain medicine after surgery?

Eligibility Criteria

Inclusion Criteria: * Aged 18 years or older * Scheduled to undergo robotic-assisted surgery at New York-Presbyterian/Weill Cornell Medical Center * American Society of Anesthesiologists physical status I-III * Able to understand and provide written informed consent in English Exclusion Criteria: * American Society of Anesthesiologists physical status IV or higher (i.e. a severe systemic disease that is a constant threat to life such as decompensated heart failure) * Chronic opioid use (≥30 morphine milligram equivalents per day for ≥30 days within the past 6 months) * Current pregnancy * Inability to understand and provide informed consent in English * Inability to provide informed consent due to cognitive impairment or other conditions impacting decision-making capacity * Scheduled open or laparoscopic surgeries

Contact & Investigator

Central Contact

Cheguevara Afaneh, MD

✉ cha9043@med.cornell.edu

📞 (646) 962-8462

Principal Investigator

Cheguevara Afaneh, MD

PRINCIPAL INVESTIGATOR

New York-Presbyterian/Weill Cornell Medical Center

Frequently Asked Questions

Who can join the NCT07710352 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Robotic Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07710352 currently recruiting?

Yes, NCT07710352 is actively recruiting participants. Contact the research team at cha9043@med.cornell.edu for enrollment information.

Where is the NCT07710352 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT07710352 clinical trial?

NCT07710352 is sponsored by Weill Medical College of Cornell University. The principal investigator is Cheguevara Afaneh, MD at New York-Presbyterian/Weill Cornell Medical Center. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology